Menometrorrhagia in magnetic resonance imaging operators with copper intrauterine contraceptive devices (IUDS): a case report by Gobba, Fabriziomaria et al.
97
C A S E  R E P O R T S
International Journal of Occupational Medicine and Environmental Health 2012;25(1):97 – 102
DOI 10.2478/s13382-012-0005-y
MENOMETRORRHAGIA IN MAGNETIC  
RESONANCE IMAGING OPERATORS WITH COPPER 
INTRAUTERINE CONTRACEPTIVE DEVICES (IUDS): 
A CASE REPORT
FABRIZIOMARIA GOBBA1, NADIA BIANCHI2, PAOLO VERGA3, GIAN MARCO CONTESSA4,  
and PAOLO ROSSI4
1 University of Modena and Reggio Emilia, Modena, Italy 
Department of Public Health Sciences 
2 Regional Health Service, Varese, Italy 
Radioprotection Unit
3 S. Carlo Borromeo Hospital, Milano, Italy
4 Italian Worker’s Compensation Authority (INAIL), Rome, Italy
Abstract
The paper describes the cases of 3 female health operators with implanted copper IUDs, developing menometrorrhagia 
some months after an increase of the working time in a Magnetic Resonance Imaging (MRI) Unit (1.5 T), that progressively 
disappeared when the previous organization, involving discontinuous work shifts at MRI, was re-established. No known 
factors possibly related to menometrorrhagia were evidenced in the 3 operators, supporting the hypothesis of a role of the 
exposure to the electromagnetic fields (EMF) induced by the MRI system in symptoms induction. The possible mechanism 
remains unsettled, but menometrorrhagia might be triggered by a phlogistic stimulus caused by EMF, possibly the low-
frequency currents induced in the wires of the IUD during the movements of the operator inside the static magnetic field 
generated by the MRI permanent magnet. Until now, the problem of possible interactions between copper IUDs and EMF 
induced by MRI has been considered in patients undergoing imaging, but the possible risk in MRI Units operators has 
been largely neglected. To our knowledge, the occurrence of menometrorrhagia is not routinely checked in health surveil-
lance of MRI operators, so these symptoms can pass unnoticed, especially if they are transitory. Therefore, underreporting 
is rather possible. The cases described here support the need for further research on this topic, especially considering the 
progressive diffusion of more powerful MRI scanners (3 T and more), and of the interventional magnetic resonance imag-
ing, both potentially involving higher EMF exposures, and a large number of MRI female operators, possibly using IUDs. 
The possibility that MRI operators with implanted metallic IUDs can be included in the group of “workers at particular 
risk” according to the EU Directive 2004/40/EC should be considered.
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personnel during MRI scanning is usually limited to a few 
specific situations, as in some cardiological examinations 
in anesthetized patients, or assistance to children, but 
health personnel (and maintenance staff) at MRI Units 
are currently exposed to the static magnetic field (SMF) 
generated by the magnet. The motion of subjects along 
a field gradient, or the rotational motion while working in 
the MRI room can induce significant low-frequency cur-
rents inside the body, which has been estimated in some 
studies [10,11].
To our knowledge, the problem of implanted IUDs 
in MRI Unit personnel has so far been neglected, and 
no data is currently available on the possible risk related 
to EMF generated by the MRI equipment in these subjects. 
We hereby describe three cases of menometrorrhagia ob-
served in female workers of an MRI unit. 
CASE PRESENTATION 
In the Radiology Department of a hospital in a Milan area 
(Lombardy Region, Italy), a 1.5 T MRI scanner has been 
in use since 2004. Among the female personnel of the Unit, 
six radiology technicians and 1 nurse, aged 23–36 years, 
have been engaged in MRI procedures. The usual acti-
vity of technicians and nurses was limited to the assistance 
to the patients, but as a rule they were not present dur-
ing the MRI scanning. Accordingly, they were exposed to 
the SMF but, customarily, not to radiofrequency nor gra-
dient time-varying magnetic fields related to the scanning. 
The operators moved randomly inside the SMF, often very 
close to the gantry. An exposure during MRI scanning was 
possible, but really uncommon, limited to occasional situ-
ations as in case of assistance to children. 
In 2004 and 2005, the personnel of the Department was 
on duty in the MRI Unit based on a rotational system, 
one week per month. Work shifts in the MRI Unit usually 
lasted 8 hours per day, even though overtime was not ex-
ceptional, especially in the case of emergencies. 
INTRODUCTION
The possible safety risk related to Magnetic Resonance 
Ima ging (MRI) in patients with implanted intrauterine 
contraceptive devices (IUDs) is a known problem [1]. In 
this context, the main types of IUD devices that can be dis-
tinguished are the metal-containing/metal-free intrauter-
ine device (IUD), the fully metal-free hormone-contain-
ing intrauterine system (IUS), and the ESSURE, an insert 
made of stainless steel, in use in Europe since 2001 [2,3]. 
The main concern was related to the possibility that, in 
patients with metal-containing IUD or with ESSURE, an 
injury can be induced by heating, or movement of the de-
vice during scanning [4–6]. An additional concern was that 
the diagnostic accuracy of the image would be impaired by 
artifact created by the device [7]. For these reasons, in the 
past, the presence of IUD was considered a limit to MRI 
scanning, but the conclusion of more recent studies is that 
up to a magnetic field strength of 1.5 T there is no risk 
of any movement or dislodgement of both the IUD and 
the ESSURE, and that a possible temperature increase, 
if any, is within the physiologic range, at least if the IUDs 
are placed in fixed position inside the bore of the MRI sys-
tem [4–6]. Accordingly, intrauterine contraceptive devices 
are currently considered safe for patients imaged with MR 
systems operating at 1.5 T or less [1,4–6,8]. 
At 3 T or above, only the metal-free IUDs and the IUS are 
considered MRI-safe, while metal-containing IUDs and 
the ESSURE have not yet been considered adequately 
evaluated [2], and the American Society for Testing and 
Materials and the Food and Drug Administration classi-
fied IUD as “MR conditional” [7,9]. 
The aforementioned evaluations substantially concern 
patients undergoing MRI for medical reasons. Neverthe-
less, an exposure to electromagnetic fields (EMF) occurs 
also in personnel working with, and around, the medi-
cal MR equipment, including radiology technicians, nurs-
es, radiologists, anesthetists and surgeons, and also the 
maintenance and cleaning staff [10,11]. The presence of 
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In the other 2 women working in the MRI Unit no meno-
metrorrhagia was reported. 
Due to the observation of the appearance of menome-
trorrhagia, in the majority of the female MRI personnel, 
after an increase of time on duty at the Unit, a possible 
role of MRI-related electromagnetic fields (EMF) was 
hypothe sized, and the problem was discussed with the hos-
pital management. Even tough the actual role of EMF in 
the symptoms appearance was not established, a decision 
was taken to reduce the exposure; consequently the previ-
ous work organization of the Radiology Department (one 
week/month on duty in the MRI Unit) was restored. 
In the following year, according to the HS recordings, 
menometrorrhagia slowly subsided in the 3 women bear-
ing IUDs, while no significant change was noted by the two 
women taking oral contraceptives. 
Increased menstrual bleeding, often with pain, is considered 
one of the most common problem of IUD use, especially 
during the first months after application, and it is the most 
common medical reason for removing IUDs: in clinical trials 
about 4% to 15% of women stop using IUDs for this reason 
within a year after insertion [3]. With regards to our case 
report, we have to observe that the workers had been using 
the IUDs for some years without any apparent bleeding. 
The symptoms started after a significant increase of the 
time spent working in the MRI Unit (continuous activ-
ity instead of 1 week/month, as previously), and gradu-
ally subsided after the newly introduced work system in 
the MRI Unit was discontinued (1 week/month).
Both other two workers (without IUDs) complaining of 
menometrorrhagia took gestodene/ethinyl estradiol oral 
contraceptives. Abnormal uterine bleeding is a common 
side effect of all forms of hormonal contraception [12]. 
Furthermore, at least in one case, POS was diagnosed, 
which could be responsible for the symptom [13]. Accord-
ing to the HS records, in both workers, menometrorrhagia 
remained substantially unmodified after re-establishing 
the previous “one week/month at MRI” work organization. 
In 2006, the work schedule was re-organized, and full-
month shifts in the MRI Unit were adopted. In 2007, the 
one-week/month MRI shifts were re-established.
The whole personnel of the Radiology Department un-
derwent a yearly medical examination by an occupational 
physician, as part of the program of health surveillance 
(HS) of the hospital staff. Apparently, until 2006, no re-
markable health problems had been reported by the Ra-
diology Department staff. During the examinations per-
formed in 2006 (second half), in five out of the 7 MRI Unit 
female health professionals, menometrorrhagia (irregular 
or excessive bleeding during menstruation and/or between 
menstrual periods) was recorded. The symptom was unex-
pected, so medical records of all the female personnel of 
the MRI Unit were revised. 
Three of the 5 subjects reporting menometrorrhagia, 
aged 33, 40 and 43 years old, had an implanted copper 
T3 IUD. According to the medical history, no pre vious 
gynecological disorders had been recorded, and the 
symptoms appeared after some weeks of full-month work 
in the MRI Unit. During the visit, the operators stated 
that the symptoms were persistent for about 6 months 
or more, without any significant variation over the time. 
None of these 3 subjects contacted a specialist in connec-
tion with the symptoms. The blood count was normal, 
and neither symptoms suggesting endocrine or systemic 
disorders, nor persistent bleeding, dyspareunia, dysme-
norrhea, pelvic pain and vaginal discharge, were report-
ed. No other investigations, such as pelvic ultrasound, 
were performed. 
Menometrorrhagia was also reported by two MRI Unit 
healthcare professionals not using IUDs, both taking oral 
gestodene/ethinyl estradiol contraceptives. In one case, 
the worker was unsure regarding the period of appear-
ance of the symptom, while in the other, menometrorrha-
gia had pre-existed for some years, and Polycystic Ovary 
Syndrome (POS) had previously been diagnosed in a gy-
necological examination. 
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of the work involved a change of activity (whole month in 
the MRI Unit, instead of 1 week/month) rather than in 
an increase in scope of the daily activity. Other common 
causes for menometrorrhagia were not identified from 
medical records [14].
The possible mechanism for MRI-related EMF bleeding 
induction can only be presumed. The copper IUD used by 
the operators consisted of a plastic core body, surrounded 
by copper wires [15]. Up to magnetic field strength of 1.5 T, 
as in this case, literature data does not support the pos-
sibility of heating or movements of the IUD during scan-
ning [1,4–6,8]. Nevertheless, so far (to our knowledge) stud-
ies have taken into account only the case of IUDs placed 
in fixed positions inside the bore. This situation is rather 
different from the case of MRI operators: copper is dia-
magnetic, and the movement inside the SMF can cause 
a magnetic flux inside the wires of the IUD, inducing low-
frequency currents depending on the strength, position, 
speed, etc. [15], and the interaction of the involved physi-
cal quantities with the living tissues can result in different 
outcomes. Especially in case of prolonged exposures, the 
direct influence of the induced currents to the tissues might 
be responsible for a phlogistic stimulus to the mucosa, lead-
ing to bleeding. This hypothesis may be applied to the three 
IUD-bearing women presented in this case report: when 
work in the MRI Unit was 1 week/month, the exposure 
was discontinued, and the stimulus was insufficient to cause 
menometrorrhagia (or the symptoms were so mild that they 
were not noticed), but when work in the MRI Unit was ex-
tended to last for the whole month, exposure was contin-
ued, and the phlogistic stimulus became sufficient to induce 
overt clinical symptoms. 
Similar observations in MRI workers are very limited, but, 
according to our knowledge, the occurrence of menometror-
rhagia is not routinely evaluated in the health surveillance 
of MRI operators, so these symptoms can pass unnoticed, 
especially if they are transitory. Therefore, underreporting is 
possible/likely. In any case, we have to observe that at least 
So far, data on the possible effects induced by MRI in 
women with IUDs is mainly limited to an evaluation of the 
possible effects in patients undergoing MRI imaging for 
medical reasons, often using models [4,7,9]. Very few cases 
of pelvic discomfort, cramping and bleeding – while having 
magnetic resonance imaging of the pelvic area – have been 
described [4], but bleeding, or menometrorrhagia, following 
an MRI scan can pass unnoticed, especially in case of transi-
tory symptoms, and, accordingly, underreporting is possible. 
Another aspect to be considered here is that the exposure 
to MRI-related fields is very different between patients 
and operators. In fact, health personnel members are 
rarely exposed to the fields generated by imaging (except 
in specific cases, as in cardiological examination in anes-
thetized patients or children assistance), but are currently 
exposed to the SMF related to the permanent magnet of 
the MRI Unit, and to the low-frequency currents induced 
by the movement of subjects inside the SMF [10]. Although 
the patients are exposed to the static field as well, the dif-
ferences between the patients and MRI staff are relevant, 
e.g. in terms of movements (e.g. length, speed, position) 
and exposure time (patients are exposed for some minu-
tes, while health personnel for several hours a day during 
the whole working week). 
In the cases described here, menometrorrhagia appeared 
when the duty in the MRI Unit was extended to the whole 
month instead of one week/month; moreover the symptoms 
were contemporarily present in the 3 women with implant-
ed IUD, and subsided following a reduction of the expo-
sure due to duty reorganization, along with an absence of 
significant gynecological disorders recorded in their medi-
cal history. This data supports a possible link between the 
exposure to MRI-related EMF and the symptoms. 
As excessive physical effort is among the possible causes of 
menometrorrhagia [14], the possibility that the symptoms 
were related to an increase of the work-load linked to the 
change of work-organization cannot be totally excluded, 
but we have to consider the fact that the re-organization 
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More generally, our results support that further research 
in the field is needed for a more accurate and compre-
hensive risk assessment, and to effectively protect MRI 
personnel. 
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